Related Experiment Video
Updated: Feb 22, 2026
10:26
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
18.0K
DVT Prevention in Stroke.
Christopher Goshgarian1, Philip B Gorelick2,3
1Mercy Health Hauenstein Neurosciences, 220 Cherry Street SE, Room H 3037, Grand Rapids, MI, 49503, USA. christopher.goshgarian@mercyhealth.com.
Current Neurology and Neuroscience Reports
|September 19, 2017
Summary
Venous thromboembolism (VTE) prevention in stroke patients is crucial. Non-vitamin K antagonist oral anticoagulants (NOACs) offer a safe and effective alternative to warfarin for VTE prophylaxis.
Area of Science:
- Neurology
- Cardiology
- Vascular Medicine
Background:
- Venous thromboembolism (VTE) is a significant complication in stroke patients.
- Traditional VTE prophylaxis has relied on warfarin and vitamin K antagonists.
- Emerging anticoagulant therapies necessitate a review of current VTE prevention strategies.
Purpose of the Study:
- To review current strategies for preventing venous thromboembolism (VTE) in stroke patients.
- To discuss the role of oral anticoagulation, including novel agents, in VTE prevention.
- To examine available data and guidance statements for VTE prophylaxis in this population.
Main Methods:
- Literature review of studies on VTE prevention in stroke patients.
- Analysis of clinical trial data for non-vitamin K antagonist oral anticoagulants (NOACs).
- Evaluation of current clinical practice guidelines and recommendations.
Main Results:
- Non-vitamin K antagonist oral anticoagulants (NOACs) have demonstrated non-inferiority to warfarin for VTE prevention and treatment with a favorable safety profile.
- Established VTE prevention methods include graduated compression stockings, intermittent pneumatic compression, inferior vena cava filters, and heparins.
- NOACs are now indicated for stroke and systemic embolism prevention in nonvalvular atrial fibrillation and for VTE treatment/prevention.
Conclusions:
- The selection of appropriate VTE prophylaxis is critical for reducing morbidity and mortality in stroke patients.
- NOACs represent a significant advancement in VTE prevention, offering an effective and safe alternative.
- Ongoing evaluation of evidence and guidelines is essential for optimizing VTE management post-stroke.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
397
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
397
01:30Venous Thrombosis IV: Nursing Management
285
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
285
01:30Venous Thrombosis I: Introduction
533
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
533
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
367
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
367
01:27Pulmonary Embolism III: Nursing Management
491
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
491
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K